VAERS Explorer
Back to explore

Report #2825499

Received Feb 10, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
—
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALSUNK5Y4TL—

Symptoms (1)

Product preparation issue

Symptom narrative

patient received only the diluent; patient received only the diluent; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate preparation of medication in a female patient who received Herpes zoster (Shingrix) (batch number 5Y4TL, expiry date 31-JAN-2027) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: patient received only the diluent ) and inappropriate dose of vaccine administered (Verbatim: patient received only the diluent). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown. Additional Information: GSK Receipt Date: 06-FEB-2025 A medical assistant called to report that a patient received only the diluent portion of Shingrix. The Healthcare professional asked for recommendations on this situation and if she could get an additional diluent vial. The patient received only diluent of Shingrix, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.